Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Emory University
Sanford Health
National Cancer Institute (NCI)
University of Birmingham
Celldex Therapeutics
Vanderbilt-Ingram Cancer Center
The Netherlands Cancer Institute
University of Alabama at Birmingham
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
University Health Network, Toronto
University of Arizona
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
University Hospital, Strasbourg, France
Pharmacyclics LLC.